Cargando…

Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West–East Collaborative Effort

Since the introduction of Milan Criteria, all scoring models describing the prognosis of hepatocellular cancer (HCC) after liver transplantation (LT) have been exclusively based on characteristics available at surgery, therefore neglecting the intention-to-treat principles. This study aimed at devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Quirino, Vitale, Alessandro, Halazun, Karim, Iesari, Samuele, Viveiros, André, Bhangui, Prashant, Mennini, Gianluca, Wong, Tiffany, Uemoto, Shinji, Lin, Chih-Che, Mittler, Jens, Ikegami, Toru, Zhe, Yang, Zheng, Shu-Sen, Soejima, Yuji, Hoppe-Lotichius, Maria, Chen, Chao-Long, Kaido, Toshimi, Lo, Chung Mau, Rossi, Massimo, Soin, Arvinder Singh, Finkenstedt, Armin, Emond, Jean C., Cillo, Umberto, Lerut, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072306/ https://www.ncbi.nlm.nih.gov/pubmed/32075133 http://dx.doi.org/10.3390/cancers12020452

Ejemplares similares

Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation
por: Lai, Quirino, et al.
Publicado: (2022)

Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence
por: Lai, Quirino, et al.
Publicado: (2023)

Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
por: Vitale, Alessandro, et al.
Publicado: (2021)

End-stage renal disease is a risk factor for complex laparoscopic cholecystectomy in patients waiting for renal transplantation
por: Colozzi, Sara, et al.
Publicado: (2019)

The role of the comprehensive complication index for the prediction of survival after liver transplantation
por: Lai, Quirino, et al.
Publicado: (2020)

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
por: Iesari, Samuele, et al.
Publicado: (2017)

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?
por: Lai, Quirino, et al.
Publicado: (2018)

Comprehensive guide to laparoscope-assisted graft harvesting in live donors for living-donor liver transplantation: perspective of laparoscopic vision
por: Hori, Tomohide, et al.
Publicado: (2017)

Nutritional Therapy in Liver Transplantation
por: Hammad, Ahmed, et al.
Publicado: (2017)

Correction: Hammad, A.; Kaido, T.; Aliyev V.; Mandato C.; Uemoto S. Nutritional Therapy in Liver Transplantation. Nutrients 2017; 9. E1126
por: Hammad, Ahmed, et al.
Publicado: (2018)

Survival After Adrenalectomy for Metastatic Hepatocellular Carcinoma: A 25-year Institutional Experience
por: Staubitz, JI., et al.
Publicado: (2020)

Fast tracking in adult living donor liver transplantation: A case series of 15 patients
por: Bhangui, Pooja, et al.
Publicado: (2018)

Outcomes of Patients Receiving a Kidney Transplant or Remaining on the Transplant Waiting List at the Epicentre of the COVID-19 Pandemic in Europe: An Observational Comparative Study
por: Perego, Marta, et al.
Publicado: (2022)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Surgical therapy of primary hepatic angiosarcoma
por: Tripke, Verena, et al.
Publicado: (2019)

Prediction and Management of Small-for-size Syndrome in Living Donor Liver Transplantation: Methodology of the ILTS-iLDLT-LTSI Consensus Conference
por: Rela, Mohamed, et al.
Publicado: (2023)

HLA-G14bp ins/del polymorphism and post-transplant weight gain in kidney transplantation: potential implications beyond tolerance
por: Piancatelli, Daniela, et al.
Publicado: (2020)

Long-Term Outcomes of Hepatic Resection versus Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score-Matching Study
por: Kaido, Toshimi, et al.
Publicado: (2015)

Spontaneous clearance of hepatitis C virus after liver transplantation: a report of four cases
por: Tamaki, Ichiro, et al.
Publicado: (2015)

Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study)
por: Kaido, Toshimi, et al.
Publicado: (2015)

Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report
por: Iwaki, Kentaro, et al.
Publicado: (2017)

Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
por: Barbier, L., et al.
Publicado: (2011)

Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
por: Kamarajah, S. K., et al.
Publicado: (2020)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy
por: Frankul, Leana, et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes
por: Di Martino, Marcello, et al.
Publicado: (2022)

Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy
por: Ferraro, Emanuela, et al.
Publicado: (2020)

Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
por: Filipec Kanižaj, Tajana, et al.
Publicado: (2022)

Structure and surgical dissection layers of the bare area of the liver
por: Ishii, Takamichi, et al.
Publicado: (2020)

Proposal of definition and diagnostic criteria for sarcopenic obesity by ESPEN and EASO
por: Kaido, Toshimi
Publicado: (2023)

Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
por: Pitton, Michael B., et al.
Publicado: (2020)

Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones
por: Mittler, Jens, et al.
Publicado: (2022)

A Western World Perspective of Survival Benefit of Living Donor Liver Transplantation: A Commentary to the Article by Jackson et al. Published in JAMA Surgery
por: Lai, Quirino, et al.
Publicado: (2022)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far
por: Dhampalwar, Swapnil, et al.
Publicado: (2020)

The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging
por: Casella, Claudio, et al.
Publicado: (2018)

Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging
por: Affonso, Breno Boueri, et al.
Publicado: (2019)

Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features
por: Wang, Si-Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gvskfh7b6tddfuf255412lav7i